The American Heart Association Life's Simple 7 and Incident Cognitive Impairment: The REasons for Geographic And Racial Differences in Stroke (REGARDS) Study

Background Life's Simple 7 is a new metric based on modifiable health behaviors and factors that the American Heart Association uses to promote improvements to cardiovascular health (CVH). We hypothesized that better Life's Simple 7 scores are associated with lower incidence of cognitive impairment. Methods and Results For this prospective cohort study, we included REasons for Geographic And Racial Differences in Stroke (REGARDS) participants aged 45+ who had normal global cognitive status at baseline and no history of stroke (N=17 761). We calculated baseline Life's Simple 7 score (range, 0 to 14) based on smoking, diet, physical activity, body mass index, blood pressure, total cholesterol, and fasting glucose. We identified incident cognitive impairment using a 3‐test measure of verbal learning, memory, and fluency obtained a mean of 4 years after baseline. Relative to the lowest tertile of Life's Simple 7 score (0 to 6 points), odds ratios of incident cognitive impairment were 0.65 (0.52, 0.81) in the middle tertile (7 to 8 points) and 0.63 (0.51, 0.79) in the highest tertile (9 to 14 points). The association was similar in blacks and whites, as well as outside and within the Southeastern stroke belt region of the United States. Conclusions Compared with low CVH, intermediate and high CVH were both associated with substantially lower incidence of cognitive impairment. We did not observe a dose‐response pattern; people with intermediate and high levels of CVH had similar incidence of cognitive impairment. This suggests that even when high CVH is not achieved, intermediate levels of CVH are preferable to low CVH.

[1]  V. Howard,et al.  Over-the-counter and prescription sleep medication and incident stroke: the REasons for Geographic and Racial Differences in Stroke study. , 2014, Journal of stroke and cerebrovascular diseases : the official journal of National Stroke Association.

[2]  V. Vaccarino,et al.  Life’s Simple 7 and Risk of Incident Stroke: The Reasons for Geographic and Racial Differences in Stroke Study , 2013, Stroke.

[3]  D. Jacobs,et al.  Cardiovascular health through young adulthood and cognitive functioning in midlife , 2013, Annals of neurology.

[4]  R. Sacco,et al.  Ideal Cardiovascular Health Predicts Lower Risks of Myocardial Infarction, Stroke, and Vascular Death Across Whites, Blacks, and Hispanics: The Northern Manhattan Study , 2012, Circulation.

[5]  Glenn E. Smith,et al.  Predicting functional ability in mild cognitive impairment with the Dementia Rating Scale-2 , 2012, International Psychogeriatrics.

[6]  C. Moy,et al.  Vascular risk factors and cognitive impairment in a stroke-free cohort , 2011, Neurology.

[7]  C. Moy,et al.  Incident cognitive impairment is elevated in the stroke belt: The REGARDS Study , 2011, Annals of neurology.

[8]  R. Sacco Achieving ideal cardiovascular and brain health: opportunity amid crisis: Presidential Address at the American Heart Association 2010 Scientific Sessions. , 2011, Circulation.

[9]  A. Folsom,et al.  Community prevalence of ideal cardiovascular health, by the American Heart Association definition, and relationship with cardiovascular disease incidence. , 2011, Journal of the American College of Cardiology.

[10]  C. Moy,et al.  Disparities in stroke incidence contributing to disparities in stroke mortality , 2011, Annals of neurology.

[11]  Mike R. Schoenberg,et al.  Defining mild cognitive impairment: impact of varying decision criteria on neuropsychological diagnostic frequencies and correlates. , 2010, The American journal of geriatric psychiatry : official journal of the American Association for Geriatric Psychiatry.

[12]  L. Vaughan,et al.  Executive function in daily life: Age-related influences of executive processes on instrumental activities of daily living. , 2010, Psychology and aging.

[13]  V. Howard,et al.  Calculating Cornell voltage from nonstandard chest electrode recording site in the Reasons for Geographic And Racial Differences in Stroke study. , 2010, Journal of electrocardiology.

[14]  D. Mozaffarian,et al.  Defining and Setting National Goals for Cardiovascular Health Promotion and Disease Reduction: The American Heart Association's Strategic Impact Goal Through 2020 and Beyond , 2010, Circulation.

[15]  Kristine Yaffe,et al.  Promising strategies for the prevention of dementia. , 2009, Archives of neurology.

[16]  V. Howard,et al.  Implications of increased C-reactive protein for cardiovascular risk stratification in black and white men and women in the US. , 2009, Clinical chemistry.

[17]  D. Singer,et al.  Antithrombotic therapy in atrial fibrillation: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines (8th Edition). , 2008, Chest.

[18]  A. Hofman,et al.  Measuring Cognitive Function With Age: The Influence of Selection by Health and Survival , 2008, Epidemiology.

[19]  J. Zbilut,et al.  Women tolerate drug therapy for coronary artery disease as well as men do, but are treated less frequently with aspirin, beta-blockers, or statins. , 2008, Gender medicine.

[20]  M. Aguilar,et al.  Meta-analysis: Antithrombotic Therapy to Prevent Stroke in Patients Who Have Nonvalvular Atrial Fibrillation , 2007, Annals of Internal Medicine.

[21]  Stef van Buuren,et al.  Multiple imputation of discrete and continuous data by fully conditional specification , 2007 .

[22]  S. van Buuren Multiple imputation of discrete and continuous data by fully conditional specification , 2007, Statistical methods in medical research.

[23]  A. Zaslavsky,et al.  Relationship between quality of care and racial disparities in Medicare health plans. , 2006, JAMA.

[24]  Dan M. Roden,et al.  ACC/AHA/ESC 2006 guidelines for management of patients with ventricular arrhythmias and the prevention of sudden cardiac death: A report of the American College of Cardiology/American Heart Association Task Force and the European Society of Cardiology Committee for Practice Guidelines , 2006 .

[25]  G. Lip,et al.  Patient knowledge and perceptions of atrial fibrillation and anticoagulant therapy: effects of an educational intervention programme. The West Birmingham Atrial Fibrillation Project. , 2006, International journal of cardiology.

[26]  A. Vanderplas,et al.  Treatment patterns and real-world effectiveness of warfarin in nonvalvular atrial fibrillation within a managed care system* , 2005, Current medical research and opinion.

[27]  C. Moy,et al.  The Reasons for Geographic and Racial Differences in Stroke Study: Objectives and Design , 2005, Neuroepidemiology.

[28]  H. Tuokko,et al.  A comparison of methods for measuring cognitive change in older adults. , 2005, Archives of clinical neuropsychology : the official journal of the National Academy of Neuropsychologists.

[29]  Mark Woodward,et al.  Imputations of missing values in practice: results from imputations of serum cholesterol in 28 cohort studies. , 2004, American journal of epidemiology.

[30]  P. O'Brien,et al.  Reliability of the Questionnaire for Verifying Stroke-Free Status , 2003, Cerebrovascular Diseases.

[31]  Yuchiao Chang,et al.  Anticoagulation therapy for stroke prevention in atrial fibrillation: how well do randomized trials translate into clinical practice? , 2003, JAMA.

[32]  K. Bennett,et al.  Evidence for an age and gender bias in the secondary prevention of ischaemic heart disease in primary care. , 2003, British journal of clinical pharmacology.

[33]  Christopher M Callahan,et al.  Six-Item Screener to Identify Cognitive Impairment Among Potential Subjects for Clinical Research , 2002, Medical care.

[34]  M. Rich,et al.  Validation of clinical classification schemes for predicting stroke: results from the National Registry of Atrial Fibrillation. , 2001, JAMA.

[35]  L. Williams,et al.  Validating the Questionnaire for Verifying Stroke-Free Status (QVSFS) by Neurological History and Examination , 2001, Stroke.

[36]  D. Singer,et al.  Prevalence of diagnosed atrial fibrillation in adults: national implications for rhythm management and stroke prevention: the AnTicoagulation and Risk Factors in Atrial Fibrillation (ATRIA) Study. , 2001, JAMA.

[37]  L. Kalra,et al.  Prospective cohort study to determine if trial efficacy of anticoagulation for stroke prevention in atrial fibrillation translates into clinical effectiveness , 2000, BMJ : British Medical Journal.

[38]  E. Tangalos,et al.  Diagnostic accuracy of four approaches to interpreting neuropsychological test data. , 2000, Neuropsychology.

[39]  D. Singer,et al.  Warfarin Use among Ambulatory Patients with Nonvalvular Atrial Fibrillation: The AnTicoagulation and Risk Factors in Atrial Fibrillation (ATRIA) Study , 1999, Annals of Internal Medicine.

[40]  M. Kamalesh,et al.  Management of atrial fibrillation. , 1992, The New England journal of medicine.

[41]  O. Selnes A Compendium of Neuropsychological Tests , 1991, Neurology.

[42]  J. Morris,et al.  The Consortium to Establish a Registry for Alzheimer's Disease (CERAD). Part I. Clinical and neuropsychological assesment of Alzheimer's disease , 1989, Neurology.

[43]  G Block,et al.  A data-based approach to diet questionnaire design and testing. , 1986, American journal of epidemiology.